A Filipino-owned company is putting up a multibillion-peso facility that will manufacture the “next generation” coronavirus disease 2019 (Covid-19) vaccine.

Giovanni Alingog, chief executive officer of Glovax Biotech Corp., aims to build a production plant either in Subic in Zambales or Clark in Pampanga.

Premium Subscription
Less than P 71 per month
(billed annually at P 850)
  • Unlimited ad-free access to website articles
  • Access to subscriber exclusive website contents
  • Access to the Digital Edition (up to 3 devices)

Digital + Print
P 740 per month
(billed annually at P 8,880)
  • Ad-free online access
  • Access to the Digital Edition
  • Print copies**
***Delivery charges may apply to subscribers outside of Metro Manila

(No free trial for this plan)